Limited Clinical Evidence: Although promising, just a few large-scale clinical trials have been done to confirm long-term effectiveness and safety
GHK-Cu differs from other signal peptides (Matrixyl, acetyl hexapeptide-8, palmitoyl tripeptides) in its copper-coordinated mechanism and broad gene-expression effects
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared BPC-157 for therapeutic use in humans or animals
Studies: Muscle strength and hypertrophy: A meta-analysis published in the Journal of the International Society of Sports Nutrition found that creatine supplementation significantly improves strength and lean body mass in various populations
For researchers investigating multi-compound protocols, BPC-157 is also available as part of the Wolverine Stack (BPC-157 + TB-500) research paradigm, and is a component of the KLOW Blend